BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/14/2019 1:31:33 PM | Browse: 936 | Download: 1569
 |
Received |
|
2019-04-19 02:35 |
|
Peer-Review Started |
|
2019-04-19 02:37 |
|
To Make the First Decision |
|
2019-06-10 08:02 |
|
Return for Revision |
|
2019-06-11 01:15 |
|
Revised |
|
2019-06-27 22:37 |
|
Second Decision |
|
2019-07-01 09:43 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-07-03 01:08 |
|
Articles in Press |
|
2019-07-03 01:08 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-08-14 07:12 |
|
Publish the Manuscript Online |
|
2019-08-14 13:31 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Elderly patients with inflammatory bowel disease: Updated review of the therapeutic landscape
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jean-Frédéric LeBlanc, Daniel Wiseman, Peter L Lakatos and Talat Bessissow |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Talat Bessissow, FRCP (C), FRCPC, MD, MSc, Associate Professor, Doctor, Doctor, Postdoctoral Fellow, Staff Physician, Division of Gastroenterology, McGill University Health Centre, 1650 Avenue Cedar C7-200, Montreal H3G1A4, QC, Canada. talat.bessissow@mcgill.ca |
| Key Words |
Inflammatory bowel disease; Elderly; Outcomes; Glucocorticoids; Biological therapy; Surgery |
| Core Tip |
Two types of inflammatory bowel disease (IBD) exist in the elderly (patients aged 60 or over): adult-onset vs elderly-onset. Disease phenotypes, outcomes and drug regimens may change based on the type of IBD. Recently, population-based trials have suggested increased corticosteroid use and decreased utilization of biologic agents in the elderly IBD population compared to their younger counterparts, likely owing to the perceived high rates of infections and malignancy from anti-tumor necrosis factor (TNF) agents. This article reviews the current available literature on the management of inflammatory bowel disease in the elderly patients, including anti-TNF agents, anti-integrin molecules, anti-interleukin 12/23 agents and IBD-related surgeries. |
| Publish Date |
2019-08-14 13:31 |
| Citation |
LeBlanc JF, Wiseman D, Lakatos PL, Bessissow T. Elderly patients with inflammatory bowel disease: Updated review of the therapeutic landscape. World J Gastroenterol 2019; 25(30): 4158-4171 |
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i30/4158.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i30.4158 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
